DIAGNOSIS AND TREATMENT OF HEART FAILURE
TABLE OF CONTENTS
(translated from Russian)
| Introduction | 10 |
| Chapter I. Etiology and pathogenesis of heart failure | 12 |
| Definition of "heart failure" | 12 |
| Main causes of congestive heart failure (CHF) | 14 |
| Major underlying clinical pathology in development of CHF | 16 |
| Medications that may impair cardiac function | 17 |
| Precipitating factors in heart failure | 18 |
| Pathogenesis of heart failure | 20 |
| Molecular mechanisms of cardiomyocyte dysfunction | 22 |
| Compensatory changes in heart failure | 23 |
| Correlation between pathophysiologic changes and symptoms of CHF | 26 |
| Pathophysiologic mechanisms and clinical presentation in heart failure | 27 |
| Chapter II. Diagnosis and classification of congestive heart failure | 29 |
| Suggestive signs and symptoms | 29 |
| Physical evaluation | 30 |
| Third heart sound (gallop): where and how to listen? | 34 |
| Assessment plan | 36 |
| Electrocardiographic findings in patients with heart failure | 37 |
| Recommended tests for patients with CHF | 39 |
| Echocardiography and radionuclide ventriculography compared in evaluation of left-ventrivular function |
41 |
| Clinical presentation of right heart failure | 43 |
| Major causes of right heart failure | 44 |
| Classification of heart failure by V.H. Vasilenko and M.D. Strazhesko | 45 |
| NYHA functional classification | 46 |
| Classification of heart failure by objective criteria | 47 |
| Determining the severity of heart failure by objective criteria | 48 |
| Chapter III. Management of congestive heart failure (general principles) | 50 |
| Strategy of CHF management | 50 |
| Tactics of CHF management | 51 |
| Non-pharmacological treatment of CHF | 53 |
| Hospitalization and discharge of heart failure patients | 56 |
| Suggested topics for patient and family education in CHF | 57 |
| Chapter IV. Pharmacological management of congestive heart failure | 59 |
| Diuretics | 61 |
| Diuretics commonly used for heart failure | 64 |
| Vasodilators | 68 |
| Cassification of oral vasodilators and their use in CHF | 68 |
| Pharmacokinetics of nitrates | 70 |
| Nitrate dosage in patients with CHF | 71 |
| ACE-inhibitors | 73 |
| Traditional views on renin-angiotensin-aldosterone system | 74 |
| Physiologic role of angiotensin II | 75 |
| Types of receptor to angiotensin II | 76 |
| Dosage of ACE-inhibitors in CHF | 77 |
| Drug interactions with ACE-inhibitors | 78 |
| Modern understanding of angiotensin II synthesis in tissues | 79 |
| Role of angiotensin II receptor blockade in treatment of CHF | 80 |
| Cardiac glycosides | 81 |
| Mechanism of action of cardiac glycosides | 81 |
| Clinical pharmacology of cardiac glycosides | 84 |
| Pharmacological properties of cardiac glycosides | 85 |
| Pharmacokinetics of cardiac glycosides | 87 |
| Digitalis toxicity | 89 |
| Factors affecting myocardial sensetivity to digitalis | 90 |
| Electrocardiogram changes in patients taking cardiac glycosides | 92 |
| Treatment of digitalis toxicity | 95 |
| Drug interactions with cardiac glycosides | 96 |
| Antiarrhythmic therapy in patinets with CHF | 98 |
| Beta-blockers | 100 |
| Classification of beta-blockers | 102 |
| Drug interactions with beta-blockers | 107 |
| New trends in the treatment of CHF | 108 |
| Chapter V. Surgical treatment of severe heart failure | 110 |
| Heart transplantation | 110 |
| Technique for orthotopic heart transplantation | 112 |
| Artificial heart | 114 |
| Implantation of left ventricular assist device | 115 |
| Dynamic cardiomyoplasty | 116 |
| Role of coronary bypass grafting | 118 |
| Chapter VI. Diagnosis and management of acute heart failure | 120 |
| Major causes of acute heart failure | 120 |
| Major precipitating factors for decompensation of chronic heart failure | 121 |
| Clinical picture of pulmonary edema | 122 |
| Diagnosis of pulmonary edema | 123 |
| Treatment of pulmonary edema | 124 |
| Principal pharmacological properties of major sympathomimetic amines | 130 |
| Pharmacological features of major sympathomimetic amines | 131 |
| Initial diagnostic evaluation of cardiogenic shock/near shock | 133 |
| Therapeutic management of cardiogenic shock/near shock | 136 |
| Recommendations for intra-aortic balloon counterpulsation in heart failure | 141 |
| Chapter VII. Clinical use of intra-aortic balloon pumping (IABP) | 143 |
| Theory of IABP | 144 |
| Timing | 151 |
| Indications for IABP | 152 |
| Contraindications for IABP | 152 |
| Complications of IABP | 155 |
| Suggestions to ensure effective IABP | 156 |
| Self-assessment questions | 157 |
| Appendix. Major clinical trials in the treatment of CHF | 158 |
| Bibliography | 188 |
| List of slides | 201 |
© V. Kryzhanovski, 1996